Research on Neurological Prognosis of Patients Undergoing Heart Valve Surgery

NCT ID: NCT05539261

Last Updated: 2022-09-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-10

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to clarify the changes of neurocognitive function of patients undergoing cardiac valve disease before and after surgical treatment under cardiopulmonary bypass operation, and to predict the neurological prognosis of such patients through combined imaging technology, so as to improve and avoid the occurrence of postoperative neurological dysfunction in such patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study focuses on brain protection in patients with heart disease. The preoperative brain imaging and consciousness and cognition evaluation results, intraoperative brain monitoring indicators, adverse events of neurological function, brain imaging and consciousness and cognition evaluation results during the postoperative and follow-up periods were recorded. At the same time, serum markers related to perioperative neurological function were obtained to explore the relevant factors affecting neurocognitive function during the perioperative period. The research objectives to investigate the perioperative changes of neurocognitive function in patients undergoing heart valve surgery under cardiopulmonary bypass and the related factors affecting the prognosis of neurocognitive function.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Valve Diseases Image

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HVD

Heart Valve Disease

magnetic resonance image

Intervention Type DEVICE

Imaging data were collected in a strong magnetic field

Neuropsychological scale

Intervention Type DIAGNOSTIC_TEST

Multi dimensional neuropsychological test

HC

Healthy controls

magnetic resonance image

Intervention Type DEVICE

Imaging data were collected in a strong magnetic field

Neuropsychological scale

Intervention Type DIAGNOSTIC_TEST

Multi dimensional neuropsychological test

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

magnetic resonance image

Imaging data were collected in a strong magnetic field

Intervention Type DEVICE

Neuropsychological scale

Multi dimensional neuropsychological test

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 45-80 years old.
* Accept heart biological valve replacement or heart valvuloplasty.
* More than 6 years of Education.
* At baseline, the score of Mini-mental State Examination (MMSE) scale is more than 23 points

Exclusion Criteria

* Patients who failed to obtain informed consent.
* Preoperative diagnosis of stroke, epilepsy, history of craniocerebral surgery, cerebrovascular disease, psychosis and rescue patients with cardiopulmonary resuscitation before operation.
* Alcoholism, illiteracy and left-handed.
* There was severe organ hypoperfusion or organ dysfunction before operation, including: preoperative myocardial infarction \< 90 days, renal failure or dialysis, severe liver injury, digestive tract ischemia, spinal cord ischemia and iliac artery occlusion.
* There are contraindications to magnetic resonance examination, such as claustrophobia and metal implants in the body.
* Pregnant or lactating women.
* Participating in other clinical studies will affect the main indicators of this study.
Minimum Eligible Age

45 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xi'an Jiaotong University

OTHER

Sponsor Role collaborator

Yuncheng First Hospital

UNKNOWN

Sponsor Role collaborator

Nanjing University of Traditional Chinese Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Qianyan Liu

Principal Investgator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nengrui Guo

Role: PRINCIPAL_INVESTIGATOR

Yuncheng First Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yuncheng First Hospital

Yuncheng, Shanxi, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nengrui Guo

Role: CONTACT

0086-17635599999

LiJun Bai, phD

Role: CONTACT

0086-15129034948

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nengrui Guo

Role: primary

0086-17635599999

Lijun Bai, PhD

Role: backup

0086-15129034948

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

82071993

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.